# FingerMotion, Inc.: overview

FNGR · Nasdaq · CIK 1602409 · [Technology](/sectors/technology.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/fngr.md) · [Financials](/companies/fngr/financials.md) · [Filings](/companies/fngr/filings.md) · [Insiders](/companies/fngr/insiders.md)

Latest reported revenue: [$281.1k](/filings/0001493152-26-047254.md) for Q2 FY2027, three months to 2026-08-31, from the 10-Q filed Oct 15, 2026 (XBRL us-gaap:Revenues, accession 0001493152-26-047254).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.5](/filings/0001520138-26-000028.md) | [10.2 d](/filings/0001520138-26-000194.md) | [8.5](/filings/0001520138-26-000265.md) | [8.6](/filings/0001493152-26-047254.md) | [5.8](/filings/0001520138-26-000028.md) | [1.2 d](/filings/0001520138-26-000194.md) | [0.7](/filings/0001520138-26-000265.md) | [0.3](/filings/0001493152-26-047254.md) |
| Gross margin | % | [5.2%](/filings/0001520138-26-000028.md) | [13.1% d](/filings/0001520138-26-000194.md) | [1.8%](/filings/0001520138-26-000265.md) | [0.4%](/filings/0001493152-26-047254.md) | [4.5%](/filings/0001520138-26-000028.md) | [19.5% d](/filings/0001520138-26-000194.md) | [32.1%](/filings/0001520138-26-000265.md) | [48.6%](/filings/0001493152-26-047254.md) |
| Operating margin | % | [(18.9%)](/filings/0001520138-26-000028.md) | [(9.6%) d](/filings/0001520138-26-000194.md) | [(23.5%)](/filings/0001520138-26-000265.md) | [(17.2%)](/filings/0001493152-26-047254.md) | [(29.4%)](/filings/0001520138-26-000028.md) | [(143.1%) d](/filings/0001520138-26-000194.md) | [(297.5%)](/filings/0001520138-26-000265.md) | [(1967.2%)](/filings/0001493152-26-047254.md) |
| Net margin | % | [(19.5%)](/filings/0001520138-26-000028.md) | [(1.0%) d](/filings/0001520138-26-000194.md) | [(23.9%)](/filings/0001520138-26-000265.md) | [(17.8%)](/filings/0001493152-26-047254.md) | [(28.8%)](/filings/0001520138-26-000028.md) | [(148.1%) d](/filings/0001520138-26-000194.md) | [(309.2%)](/filings/0001520138-26-000265.md) | [(1754.8%)](/filings/0001493152-26-047254.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001520138-26-000028.md) | not reported | [(0.04)](/filings/0001520138-26-000265.md) | [(0.03)](/filings/0001493152-26-047254.md) | [(0.03)](/filings/0001520138-26-000028.md) | not reported | [(0.03)](/filings/0001520138-26-000265.md) | [(0.08)](/filings/0001493152-26-047254.md) |
| Free cash flow | $m | [(1.7) d](/filings/0001520138-26-000028.md) | [(3.6) d](/filings/0001520138-26-000194.md) | [(1.2)](/filings/0001520138-26-000265.md) | [(1.9) d](/filings/0001493152-26-047254.md) | [(0.6) d](/filings/0001520138-26-000028.md) | [(0.3) d](/filings/0001520138-26-000194.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-02-28) | FY2023 (2023-02-28) | FY2024 (2024-02-29) | FY2025 (2025-02-28) | FY2026 (2026-02-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [22.9](/filings/0001520138-23-000249.md) | [34.1](/filings/0001520138-24-000219.md) | [35.8](/filings/0001520138-25-000162.md) | [35.6](/filings/0001520138-26-000194.md) | [24.1](/filings/0001520138-26-000194.md) |
| Gross margin | % | [12.3%](/filings/0001520138-23-000249.md) | [6.8%](/filings/0001520138-24-000219.md) | [10.8%](/filings/0001520138-25-000162.md) | [7.8%](/filings/0001520138-26-000194.md) | [2.9%](/filings/0001520138-26-000194.md) |
| Operating margin | % | [(21.2%)](/filings/0001520138-23-000249.md) | [(19.6%)](/filings/0001520138-24-000219.md) | [(10.7%)](/filings/0001520138-25-000162.md) | [(16.7%)](/filings/0001520138-26-000194.md) | [(28.8%)](/filings/0001520138-26-000194.md) |
| Net margin | % | [(21.6%)](/filings/0001520138-23-000249.md) | [(22.1%)](/filings/0001520138-24-000219.md) | [(10.6%)](/filings/0001520138-25-000162.md) | [(14.3%)](/filings/0001520138-26-000194.md) | [(29.2%)](/filings/0001520138-26-000194.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001520138-23-000249.md) | [(0.17)](/filings/0001520138-24-000219.md) | [(0.07)](/filings/0001520138-25-000162.md) | [(0.09)](/filings/0001520138-26-000194.md) | [(0.12)](/filings/0001520138-26-000194.md) |
| Free cash flow | $m | [(5.9)](/filings/0001520138-23-000249.md) | [(8.7)](/filings/0001520138-24-000219.md) | [(7.3)](/filings/0001520138-25-000162.md) | [(8.2)](/filings/0001520138-26-000194.md) | [(3.9)](/filings/0001520138-26-000194.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fngr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Platform Technology Partners](/funds/1830817.md) | 2026-06-30 | $136.1k | 359,643 |  | Added +100,000 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $75.1k | 198,649 |  | Reduced −27,527 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $65.1k | 172,200 | Call | Added +11,100 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $58.1k | 153,470 |  | Added +123,089 |
| [ENVESTNET ASSET MANAGEMENT INC](/funds/1407543.md) | 2026-06-30 | $53.8k | 142,322 |  | Added +42,507 |
| [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $47.0k | 123,911 |  | Added +283 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $42.2k | 111,665 |  | Reduced −3,437 |
| [Krilogy Financial LLC](/funds/1659047.md) | 2026-06-30 | $22.7k | 60,000 |  | Unchanged |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $20.1k | 53,200 | Call | New +53,200 |
| [GROUP ONE TRADING LLC](/funds/932540.md) | 2026-06-30 | $19.2k | 50,757 |  | Reduced −64,156 |

## Recent filings

[All 365 filings](/companies/fngr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 16:29 ET | [10-Q](/filings/0001493152-26-047254.md) | Quarterly report, period 2026-08-31 | 0001493152-26-047254 |
| 2026-10-14 | 15:38 ET | [S-1/A](/filings/0001493152-26-047000.md) | Registration statement, amended | 0001493152-26-047000 |
| 2026-10-09 | 14:12 ET | [S-1/A](/filings/0001493152-26-046470.md) | Registration statement, amended | 0001493152-26-046470 |
| 2026-10-06 | 16:23 ET | [8-K](/filings/0001493152-26-045952.md) | 5.07 Shareholder vote results | 0001493152-26-045952 |
| 2026-09-29 | 16:45 ET | [8-K](/filings/0001493152-26-044880.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-044880 |
| 2026-09-11 | 18:25 ET | [8-K](/filings/0001493152-26-042255.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042255 |
| 2026-09-04 | 17:00 ET | [8-K](/filings/0001493152-26-041574.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041574 |
| 2026-09-01 | 17:15 ET | [S-1](/filings/0001493152-26-041059.md) | Registration statement | 0001493152-26-041059 |
| 2026-08-31 | 17:27 ET | [DEF 14A](/filings/0001493152-26-040877.md) | Proxy statement, period 2026-08-31 | 0001493152-26-040877 |
| 2026-08-31 | 09:00 ET | [8-K](/filings/0001493152-26-040744.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-040744 |

## Latest annual report

[Form 10-K for the fiscal year ended Feb 28, 2026](/filings/0001520138-26-000194.md), filed May 29, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1602409
- Tickers: FNGR
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 17:24 ET. No prices; not investment advice.
